Literature DB >> 1961014

Human chronic lymphocytic leukemia cells regularly express mRNAs of the protooncogenes lck and c-fgr.

H Abts1, M Jücker, V Diehl, H Tesch.   

Abstract

Protooncogenes, the cellular homologues of transforming retroviral oncogenes, have been suggested to participate in malignant transformation of various cell types. The role activated protooncogenes might play in chronic lymphocytic leukemia (CLL) is not yet clear. We investigated the expression of the protooncogenes lck and c-fgr encoding two protein tyrosine kinases by Northern-blot analysis in 21 patients with B-CLL and transcripts of both genes were detected in all cases. In contrast to CLL B cells, normal B cells from peripheral blood of a healthy donor separated by magnetic sorting did not express c-fgr and lck. The results suggest a possible role for these two protooncogenes of the src family in the activation and/or transformation of human B lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1961014     DOI: 10.1016/0145-2126(91)90103-z

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  8 in total

1.  B-1 cell lymphoma in mice lacking the steroid and xenobiotic receptor, SXR.

Authors:  Stephanie C Casey; Edward L Nelson; Gina M Turco; Matthew R Janes; David A Fruman; Bruce Blumberg
Journal:  Mol Endocrinol       Date:  2011-03-24

Review 2.  Kinase inhibitors in cancer therapy: a look ahead.

Authors:  H H Sedlacek
Journal:  Drugs       Date:  2000-03       Impact factor: 9.546

3.  Inhibition of Lck enhances glucocorticoid sensitivity and apoptosis in lymphoid cell lines and in chronic lymphocytic leukemia.

Authors:  M W Harr; P F Caimi; K S McColl; F Zhong; S N Patel; P M Barr; C W Distelhorst
Journal:  Cell Death Differ       Date:  2010-03-19       Impact factor: 15.828

4.  The steroid and xenobiotic receptor negatively regulates B-1 cell development in the fetal liver.

Authors:  Stephanie C Casey; Bruce Blumberg
Journal:  Mol Endocrinol       Date:  2012-04-11

Review 5.  Does B cell receptor signaling in chronic lymphocytic leukaemia cells differ from that in other B cell types?

Authors:  Joseph R Slupsky
Journal:  Scientifica (Cairo)       Date:  2014-07-02

6.  NFAT2 is a critical regulator of the anergic phenotype in chronic lymphocytic leukaemia.

Authors:  Melanie Märklin; Jonas S Heitmann; Alexander R Fuchs; Felicia M Truckenmüller; Michael Gutknecht; Stefanie Bugl; Sebastian J Saur; Juliane Lazarus; Ursula Kohlhofer; Leticia Quintanilla-Martinez; Hans-Georg Rammensee; Helmut R Salih; Hans-Georg Kopp; Michael Haap; Andreas Kirschniak; Lothar Kanz; Anjana Rao; Stefan Wirths; Martin R Müller
Journal:  Nat Commun       Date:  2017-10-02       Impact factor: 14.919

7.  H-2z homozygous New Zealand mice as a model for B-cell chronic lymphocytic leukemia: elevated bcl-2 expression in CD5 B cells at premalignant and malignant stages.

Authors:  H Okamoto; H Nishimura; A Shinozaki; D Zhang; S Hirose; T Shirai
Journal:  Jpn J Cancer Res       Date:  1993-12

8.  Genetic Loss of LCK Kinase Leads to Acceleration of Chronic Lymphocytic Leukemia.

Authors:  Melanie Märklin; Alexander R Fuchs; Claudia Tandler; Jonas S Heitmann; Helmut R Salih; Joseph Kauer; Leticia Quintanilla-Martinez; Stefan Wirths; Hans-Georg Kopp; Martin R Müller
Journal:  Front Immunol       Date:  2020-09-02       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.